Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Cancer Metabolomics 2018"
A special issue of Metabolites (ISSN 2218-1989).
Deadline for manuscript submissions: closed (31 December 2018).
A printed edition of this Special Issue is available here.
Interests: analytical chemistry and instrumental analysis (GC and LC-MS) for application in biological (cancer) and toxicological research
Interests: metabolomics; cancer biomarkers; metabolic pathways; cell lines; bioﬂuids
Interests: biomarker discovery using GC-MS and NMR based metabolomics for diagnosis, prognosis and treatment improvement; development of new non-invasive diagnostic tools for cancer detection, based on the profile of urinary volatile compounds
The metabolomics approach, defined as the study of all endogenously-produced low-molecular-weight compounds, appeared as a promising strategy to define new cancer biomarkers. Information obtained from metabolomic data can help to highlight disrupted cellular pathways and, consequently, contribute to the development of new-targeted therapies and the optimization of therapeutics. Therefore, metabolomic research may be more clinically translatable than other omics approaches, since metabolites are closely related to the phenotype and the metabolome is sensitive to many factors. Metabolomics seems promising to identify key metabolic pathways characterizing features of pathological and physiological states. Thus, knowing that tumor metabolism markedly differs from the metabolism of normal cells, the use of metabolomics is ideally suited for biomarker research. Some works have already focused on the application of metabolomic approaches to different cancers, namely lung, breast and liver, using urine, exhaled breath, and blood. In this Special Issue we aim to contribute a more complete understanding of cancer disease by using metabolomics approaches. We would like to invite you for your contribution in this Special Issue dedicated to “Cancer Metabolomics”. This Special Issue will be of a great help for all researchers working in this field.
Dr. Paula Guedes de Pinho
Prof. Dr. Márcia Carvalho
Dr. Joana Pinto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- untargeted metabolomics (data management, data processing and statistical analysis)
- NMR and MS analytical platforms
- translatability of model systems (cell lines, tumor tissues) to human biofluids
- cancer biomarkers
- validation of biomarkers in biofluids